Search

everythinglearnresearchcommunity

for

Search:↓

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Extracellular vesicles show promise for wound healing, but more research is needed to improve their stability and production.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

Finasteride may lower cholesterol and slow heart disease progression.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Siddha medicine uses herbs and minerals to safely treat skin diseases like psoriasis and eczema.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Melatonin, usually known for sleep regulation, also has antioxidant properties that can protect skin, stimulate hair growth, and improve skin conditions, with topical application being more effective than oral use.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Melatonin, a hormone, can help protect skin from aging by reducing stress, inflammation, and damage, and may also help treat hair loss in women.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

High mTORC1 activity slows hair growth and causes it to lose color.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

CBD may improve skin and hair health, but its effective use and safety need more research.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Nanocarriers make melatonin more effective and reduce side effects.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

The document concludes that significant investment in agricultural innovation is necessary to achieve global food security and nutrition.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Long COVID patients have more health issues than non-infected people.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Liposomes and niosomes can help drugs penetrate the skin better.